Stock split, CSE listing show evidence of company’s shareholder commitment PreveCeutical balancing need for unique profit-building intellectual property with mission to offer affordable products to patients Manufacturer agreement, licensed shipments advance CBD therapy research Alternative medicines market valued at more than $40 billion PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) dedication to developing […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.